Population pharmacokinetics of molnupiravir in adults with COVID‐19: Lack of clinically important exposure variation across individuals

• Main Authors: Sébastien Bihorel (Author), Youfang Cao (Author), Akshita Chawla (Author), Ruthie Birger (Author), Brian M. Maas (Author), Wei Gao (Author), Stefan Roepcke (Author), Susanne Sardella (Author), Rebecca Humphrey (Author), Sindhuri Kondragunta (Author), Bhuvana Jayaraman (Author), Monika Martinho (Author), Wendy Painter (Author), George Painter (Author), Wayne Holman (Author), Carisa De Anda (Author), Michelle L. Brown (Author), Matthew G. Johnson (Author), Amanda Paschke (Author), Matthew L. Rizk (Author), Julie A. Stone (Author)
• Format: Book
• Published: Wiley, 2023-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Effective antiviral treatments for coronavirus disease 2019 (COVID‐19) are needed to reduce the morbidity and mortality associated with severe acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2) infection, particularly in patients with risk factors for severe disease. Molnupiravir (MK‐448...